These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
618 related articles for article (PubMed ID: 27138035)
41. Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization. Romagnoli R; Prencipe F; Oliva P; Kimatrai Salvador M; Brancale A; Ferla S; Hamel E; Viola G; Bortolozzi R; Persoons L; Balzarini J; Liekens S; Schols D Bioorg Chem; 2020 Apr; 97():103665. PubMed ID: 32086053 [TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological evaluation of 4-phenyl-5-quinolinyl substituted isoxazole analogues as potent cytotoxic and tubulin polymerization inhibitors against ESCC. Jia M; Pei Y; Li N; Zhang Y; Song J; Niu JB; Yang H; Zhang S; Sun M Eur J Med Chem; 2024 Sep; 275():116611. PubMed ID: 38901104 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents. Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity. Romagnoli R; Baraldi PG; Salvador MK; Preti D; Aghazadeh Tabrizi M; Brancale A; Fu XH; Li J; Zhang SZ; Hamel E; Bortolozzi R; Basso G; Viola G J Med Chem; 2012 Jan; 55(1):475-88. PubMed ID: 22136312 [TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold. Xu Q; Sun M; Bai Z; Wang Y; Wu Y; Tian H; Zuo D; Guan Q; Bao K; Wu Y; Zhang W Eur J Med Chem; 2017 Oct; 139():242-249. PubMed ID: 28802124 [TBL] [Abstract][Full Text] [Related]
47. Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors. Guo S; Zhen Y; Guo M; Zhang L; Zhou G Invest New Drugs; 2018 Dec; 36(6):1147-1157. PubMed ID: 30019099 [TBL] [Abstract][Full Text] [Related]
48. Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors. Xu Q; Bao K; Sun M; Xu J; Wang Y; Tian H; Zuo D; Guan Q; Wu Y; Zhang W Sci Rep; 2017 Sep; 7(1):11997. PubMed ID: 28931885 [TBL] [Abstract][Full Text] [Related]
49. 4- and 5-aroylindoles as novel classes of potent antitubulin agents. Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504 [TBL] [Abstract][Full Text] [Related]
50. Combretastatin linked 1,3,4-oxadiazole conjugates as a Potent Tubulin Polymerization inhibitors. Kamal A; Srikanth PS; Vishnuvardhan MV; Kumar GB; Suresh Babu K; Hussaini SM; Kapure JS; Alarifi A Bioorg Chem; 2016 Apr; 65():126-36. PubMed ID: 26943479 [TBL] [Abstract][Full Text] [Related]
51. 2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors. Chuang HY; Chang JY; Lai MJ; Kuo CC; Lee HY; Hsieh HP; Chen YJ; Chen LT; Pan WY; Liou JP ChemMedChem; 2011 Mar; 6(3):450-6. PubMed ID: 21360819 [TBL] [Abstract][Full Text] [Related]
52. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles. Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393 [TBL] [Abstract][Full Text] [Related]
53. Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole. Romagnoli R; Baraldi PG; Prencipe F; Oliva P; Baraldi S; Tabrizi MA; Lopez-Cara LC; Ferla S; Brancale A; Hamel E; Ronca R; Bortolozzi R; Mariotto E; Basso G; Viola G Sci Rep; 2016 May; 6():26602. PubMed ID: 27216165 [TBL] [Abstract][Full Text] [Related]
54. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction. Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030 [TBL] [Abstract][Full Text] [Related]
55. β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells. Malebari AM; Fayne D; Nathwani SM; O'Connell F; Noorani S; Twamley B; O'Boyle NM; O'Sullivan J; Zisterer DM; Meegan MJ Eur J Med Chem; 2020 Mar; 189():112050. PubMed ID: 31954879 [TBL] [Abstract][Full Text] [Related]
56. Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site. Li W; Shuai W; Sun H; Xu F; Bi Y; Xu J; Ma C; Yao H; Zhu Z; Xu S Eur J Med Chem; 2019 Feb; 163():428-442. PubMed ID: 30530194 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues. Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074 [TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors. Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995 [TBL] [Abstract][Full Text] [Related]
59. Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents. Wang ZZ; Sun WX; Wang X; Zhang YH; Qiu HY; Qi JL; Pang YJ; Lu GH; Wang XM; Yu FG; Yang YH Chem Biol Drug Des; 2017 Aug; 90(2):236-243. PubMed ID: 28079286 [TBL] [Abstract][Full Text] [Related]
60. Synthesis and bio-evaluation of novel quinolino-stilbene derivatives as potential anticancer agents. Srivastava V; Lee H Bioorg Med Chem; 2015 Dec; 23(24):7629-40. PubMed ID: 26602827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]